Key Takeaways
- • Spot gold rose 0.4% to $1,738.34 per ounce on May 18, with U.S. gold futures gaining 0.5% to $1,742.10, driven by recession concerns and economic reopening uncertainty despite early vaccine optimism from Moderna's preliminary trial results.
- • Jeffrey Sica, founder of Circle Squared Alternative Investments, stated that "fundamentals for gold have never been better in history," positioning the asset to reach new highs unless vaccine developments accelerate market optimism further.
- • Massive global stimulus programs, perceived currency debasement risks, and geopolitical tensions—including anticipated Nasdaq restrictions on Chinese company listings—are sustaining safe-haven demand for precious metals and supporting gold's upward trajectory.
- • Precious metals across the board strengthened: palladium gained 1% to $2,032.34 per ounce, platinum jumped 1.8% to $832.47, and silver rose 0.8% to $17.31, reflecting broad-based demand for inflation hedges and risk-off positioning.
- • The gold market faces near-term headwinds from equity rally momentum following vaccine announcements, but structural demand drivers—weak economic outlook, central bank accommodation, and geopolitical risks—remain firmly in place to support prices.
Summary
The fundamental case for gold remains robust, according to market participants. Jeffrey Sica of Circle Squared Alternative Investments characterized current conditions as historically favorable for the precious metal, noting that absent additional vaccine breakthroughs, gold should experience upward momentum toward fresh record highs. Saxo Bank analyst Ole Hansen reinforced this thesis, observing that while markets focused on Monday's equity rally aftermath, underlying structural demand for gold remains intact. The weaker economic outlook, extraordinary central bank stimulus measures, and mounting geopolitical tensions all provide lasting support for prices.
Multiple factors are sustaining demand for precious metals as safe-haven assets. Massive global stimulus programs designed to mitigate coronavirus economic damage have bolstered gold's appeal as an inflation hedge and currency debasement protection. Additionally, escalating China-U.S. tensions—evidenced by Nasdaq's anticipated restrictions on Chinese company listings—are driving investors toward risk-off positioning. These geopolitical headwinds complement recession fears as economies attempt to reopen and recover from the deep slowdown triggered by the pandemic.
The strength extended across the precious metals complex. Palladium gained 1% to $2,032.34 per ounce and hit a near one-month peak of $2,109.20. Platinum jumped 1.8% to $832.47, while silver rose 0.8% to $17.31. The broad-based advance underscores institutional demand for tangible assets amid currency instability and economic uncertainty. While vaccine development represents a potential headwind to gold prices, the combination of ultra-accommodative monetary policy, recession risks, and geopolitical friction appears sufficient to maintain bullion's upward bias in the near term.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.